Project Grant R01DA063569
Award Date 6/15/26
Completion Date 3/31/31
Dollars Obligated $542K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Oakland, CA 94607, USA
Similar Awards
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded Kaiser Foundation Hospitals a $941,958 project grant on March 15, 2026, through the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct developmental research on cannabis use trajectories across the adult lifespan. The primary deliverable is preliminary analyses utilizing 10 years of electronic health record data from a large integrated health system, encompassing over 331,000 adult patients...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded The Medical University of South Carolina a Project Grant totaling $686,692 under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct prospective research on cannabis use reduction and its impact on patient functioning. Initiated on September 1, 2025, and extending through July 31, 2030, this eight-week clinical trial will enroll 176 adults aged 18 and older with Cannabis Use Disorder...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded Boston Children's Hospital a $489,500 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) beginning June 1, 2025 and concluding May 31, 2027. This research initiative develops and validates remote oral fluid testing procedures to assess cannabis non-use as a key outcome measure in clinical trials targeting younger adults aged 18-30 years with cannabis use disorder (CUD). The project...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded the Regents of the University of Michigan a $701,964 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop and evaluate a remote, behavioral economics-based intervention for cannabis use disorder (CUD). The project, initiated on June 15, 2026, and concluding March 31, 2031, addresses the critical gap in CUD treatment accessibility, as fewer than 10% of individuals with CUD...
- Federal Project Grant Award Summary Arizona State University is conducting a research study funded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) to investigate the predictors and outcomes of simultaneous cannabis and alcohol use among emerging adults. With an award of $691,107 granted on June 1, 2026, and a completion date of March 31, 2031, this project will recruit 300 emerging adults who regularly engage in simultaneous alcohol...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded the University of Southern California $149,766 on August 12, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct a research investigation on simultaneous nicotine, alcohol, and cannabis co-use among young adults. The project, which extends through May 15, 2029, utilizes data from an ongoing prospective cohort study of approximately 3,860 young adults recruited from Southern...
- Federal Project Grant Summary The National Institute on Drug Abuse (NIDA) awarded a $7.09 million Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to the University of California, Los Angeles for the period July 1, 2025, through June 30, 2029. This Avenir Award supports innovative research to reconnect scientific evidence with policy decisions affecting people who use drugs (PWUD), particularly those with comorbid HIV and substance use disorders (SUD). The project...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA), under its Drug Use and Addiction Research Programs (CFDA 93.279), awarded $248,201 to the University of Colorado-Denver on April 15, 2026, to support a two-year research project examining objective methods for detecting recent cannabis use. The project, titled "Advancing Cannabis Detection: Breath and Ocular Approaches," delivers rigorous validation of two emerging detection technologies: breath sampling devices...
- Federal Project Grant Award Summary Cambridge Health Alliance (CHA), a Harvard Medical School teaching affiliate based in East Cambridge, Massachusetts, received a $776,604 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) awarded June 15, 2026. The grant funds a convergent parallel mixed methods research initiative examining the impact of recreational cannabis legalization (RCL) on cannabis, nicotine, and alcohol...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded McLean Hospital a $736,811 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct a longitudinal cohort study of opioid use disorder. The study, initiated June 1, 2026, and extending through March 31, 2031, will follow 550 adults with opioid use disorder recruited across multiple U.S. sites to characterize the long-term course of the disorder against the evolving landscape of...